Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21705756 | 0.89 | ATM (0.37) | ALDH1A1ATMSMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL21705199 | 0.83 | ATM (0.52) | ALDH1A1ATMSMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL21911813 | 0.79 | HDAC3 (0.30) | — | |
| SCHEMBL21705249 | 0.77 | ALDH1A1 (0.46) | ALDH1A1ATMSMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL21705252 | 0.77 | ALDH1A1 (0.46) | ALDH1A1ATMSMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL21705899 | 0.77 | GAA (0.54) | ALDH1A1ATMSMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL26068000 | 0.76 | POLB (0.31) | LMNAKMT2AGAA | |
| SCHEMBL21705214 | 0.76 | KDM4E (0.50) | ALDH1A1ATMSMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL1377797 | 0.75 | ATM (0.50) | ALDH1A1ATMSMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL21705226 | 0.75 | ALDH1A1 (0.46) | ALDH1A1ATMSMN1; SMN2L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200050105-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200050105-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | HNRNPU, HNRNPR, ZFR | ALDH1A1 4859/4885ATM 3719/4885SMN1; SMN2 1618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.